Does LESTAURTINIB Cause Hypertransaminasaemia? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hypertransaminasaemia have been filed in association with LESTAURTINIB. This represents 7.5% of all adverse event reports for LESTAURTINIB.
6
Reports of Hypertransaminasaemia with LESTAURTINIB
7.5%
of all LESTAURTINIB reports
3
Deaths
3
Hospitalizations
How Dangerous Is Hypertransaminasaemia From LESTAURTINIB?
Of the 6 reports, 3 (50.0%) resulted in death, 3 (50.0%) required hospitalization.
Is Hypertransaminasaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LESTAURTINIB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does LESTAURTINIB Cause?
Febrile neutropenia (23)
Hypertriglyceridaemia (13)
Clostridium difficile colitis (10)
Death (10)
Diarrhoea (10)
Enterococcal infection (9)
Sepsis (9)
Bronchiolitis (8)
Candida infection (8)
Hypertension (8)
What Other Drugs Cause Hypertransaminasaemia?
METHOTREXATE (436)
ACETAMINOPHEN (326)
PACLITAXEL (318)
CARBOPLATIN (304)
PEMBROLIZUMAB (231)
ATORVASTATIN (207)
CYCLOPHOSPHAMIDE (202)
PREDNISONE (198)
GEMCITABINE (196)
DEXAMETHASONE (169)